1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

EKR Therapeutics

Anonymous board for EKR Therapeutics


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    43
    Views:
    14,644
  2. Anonymous
    Replies:
    8
    Views:
    9,771
  3. Anonymous
    Replies:
    8
    Views:
    6,062
  4. Anonymous
    Replies:
    20
    Views:
    9,769
  5. Anonymous
    Replies:
    7
    Views:
    5,720
  6. Anonymous
    Replies:
    11
    Views:
    4,772
  7. Anonymous
    Replies:
    6
    Views:
    5,274
  8. Anonymous
    Replies:
    18
    Views:
    8,017
  9. Anonymous
    Replies:
    6
    Views:
    5,147
  10. Anonymous
    Replies:
    0
    Views:
    3,288
  11. Anonymous
    Replies:
    0
    Views:
    2,993
  12. Anonymous
    Replies:
    1
    Views:
    2,936
  13. Scantillycladklansman
    Replies:
    17
    Views:
    7,394
  14. Anonymous
    Replies:
    3
    Views:
    4,409
  15. Anonymous
    Replies:
    32
    Views:
    11,426
  16. Anonymous
    Replies:
    69
    Views:
    21,486
  17. Anonymous
    Replies:
    3
    Views:
    4,064
  18. Anonymous
    Replies:
    9
    Views:
    5,658
  19. Anonymous
    Replies:
    15
    Views:
    7,604
  20. Anonymous
    Replies:
    1
    Views:
    3,707

Thread Display Options

Loading...